Skip to main content

Optimizing Outcomes: Multiple Myeloma

October 25, 2023

Optimizing Outcomes: Multiple Myeloma

We invite you to learn more about:

  • Treatments for myeloma
  • Emerging therapies including CAR T-cell therapies and bispecific antibodies
  • Side-effect management
  • Communicating effectively with your healthcare team

Benjamin Derman, MD
Assistant Professor, Medicine
University of Chicago
Chicago, IL

Program Support

Support for this program is provided by Genentech, Inc. & Biogen; and Janssen Oncology.

See All Resources

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.